◆ 会议时间：2025年9月25-28日
◆ 会议地点：瑞典 斯德哥尔摩
◆ 会议简介：
2025年第31届欧洲泌尿生殖放射学研讨会将于2025年9月25-28日在瑞典斯德哥尔摩举行，会议由欧洲泌尿生殖放射学会(ESUR)主办。
欧洲泌尿生殖放射学会(ESUR)成立于1990年，是一个旨在促进泌尿生殖系统成像和介入领域发展的非营利性组织。ESUR致力于提高欧洲在泌尿生殖学领域的宣研究和教育，汇集对该领域感兴趣的专业人士，组织科学会议和研究生课程，与欧洲内外的其他组织合作，就泌尿生殖放射学的各个方面进行研究，促进对正常和异常肾、尿道和生殖器官的研究，重点在X线、超声检查、CT、磁共振核医学以及任何新的成像技术以及造影剂的研究。未经本站许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com)。
31st Annual Meeting of the European Society of Urogenital Radiolog （ESUR 2025）
Date:
September 25-28, 2025
Venue:
Stockholm Waterfront Congress Centre
Stockholm, Sweden
摘要征文投稿：
IMPORTANT DATES
- Submission form available: Beginning of 2025
- Deadline for abstract submission: June 25th, 2025
- Notification of acceptance: July 21st – 25th, 2025
- Registration of one of the authors: August 6th, 2025
- Deadline to send the electronic poster: September 3rd, 2025
点此提交摘要>>>Submit Abstract>>>
The first author and co-authors must be listed with name, surname, and workplace. However, the content of the abstracts must not include the centre of origin. The appearance of this information may lead to the rejection of the abstract.
At least one of the authors must be registered for the 31st ESUR Symposium before September 3rd, 2025. Otherwise, the paper will not be accepted.
The author giving the oral presentation must be registered for the Symposium.
注册费：
| Registration Type |
Early Bird Fee(until May 13th) |
Mid Fee(until July 15th) |
Late Fee(until September 28th) |
| ESUR Faculty Member |
€ 250.00 |
€ 250.00 |
€ 250.00 |
| Member |
€ 545.00 |
€ 575.00 |
€ 610.00 |
| Non-Member |
€ 645.00 |
€ 700.00 |
€ 730.00 |
| Member Junior |
€ 260.00 |
€ 350.00 |
€ 380.00 |
| Non-Member Junior |
€ 350.00 |
€ 380.00 |
€ 415.00 |
| Radiographer |
€ 260.00 |
€ 345.00 |
€ 380.00 |
| Students |
€ 165.00 |
€ 220.00 |
€ 275.00 |
VAT will be applied in the registration process
• Coffees and lunches
• Access to all the onsite sessions
• Congress documentation
• Access to digital exhibition posters
• Attendance certificate
• CME certificate
◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|
